Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Thymosin beta4 safe in phase II corneal wound-healing study

May 6, 2010

Combined GM-CSF and agatolimod arm melanoma sentinel lymph nodes against metastasis

May 6, 2010

Pan-CDK inhibitor BAY-1000394 exhibits favorable pharmacologic profile in preclinical evaluation

May 5, 2010

LiGluR gene therapy reinstates visual responses in inherited blindness models

May 5, 2010

Antioxidant activity of dextromethorphan may be beneficial in retinitis pigmentosa

May 5, 2010

Preclinical data on nucleolin-binding peptide EP-302 support further development in cancer therapy

May 5, 2010

Cullin-1 emerges as a potential biomarker for the early diagnosis of human melanoma

May 5, 2010

Novel CRAC inhibitor synthesized at Incozen Therapeutics

May 5, 2010

AG-011 ineffective in phase II ulcerative colitis study

May 4, 2010

Clinical study, meta-analysis reveal intraocular pressure reductions with PF-4217329

May 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...